Today, an alarming number of patients are falling victim to antibiotic-resistant infections, including those like C. difficile which aren’t just resistant to conventional antibiotics but actually caused by them.  Thankfully, even when antibiotics fail to produce positive outcomes, ancient medicinal foods like honey may come to the rescue. 

A recent report published in the International Journal of Antimicrobial Agents reveals that an exotic honey may provide a powerful alternative to conventional antibiotics in treating one of the most common and deadly forms of infection in the United States today.

In a letter to the editor of the journal titled, “Successful treatment of persistent Clostridium difficile infection with manuka honey,”  two scientists from the Department of Gastroenterology and Hepatology, Elisabeth-TweeSteden Hospital, Netherlends, discuss the therapeutic potential of a honey indigneous to Australia and New Zealand known as Manuka for treating Clostridium difficile infections.

Most serious Clostridicum difficile infections are caused by antibiotic-associated depopulation of the gut flora, leading to the overgrowth of what would otherwise be harmless bacteria in most cases. For instance, about 60-70% of newborns are assymptomatically colonized by Clostridium difficle. It is only when the microbiome is assaulted with broad spectrum antibiotics that this spore-forming, Gram positive bacteria can grow out of its natural bounds to cause serious problems. We’ve also reported previously about the role of the herbicide glyphosate (aka Roundup) in contributing to deadly Clostridium infections.

In the new study researchers describe the problem of Clostridium difficile infection as follows:

“Clostridium difficile-associated disease is an increasingly common health problem. C. difficile is a causative agent of antibiotic associated pseudomembranous colitis, antibiotic-associated colitis and antibiotic-associated diarrhoea [1]. C. difficile overgrowth usually occurs during antibiotic therapy as the normal gastrointestinal flora is disrupted. Discontinuation of antibiotics does not lead to symptomatic improvement, and new strains of the pathogen have a substantial failure rate after therapy cessation [2].”

C. difficile has become one of the most worrisome infections in the US, with an estimated 453,000 cases diagnosed each year, and 29,000 of those resulting in fatalities in 2011 alone. 1 2

The conventional medical establishment is beginning to wake up to the extent of the problem. Today, it is not uncommmon to hear news reports of how conventional antibiotics are completely impotent vis-a-vis the growing scourge of antibiotic-resistant bacteria. The CDC, in fact, has recently labeled these “nightmare bacteria,” and has warned that conventional medicine will soon be completely helpless to do anything to countermand these deadly infections.

Read the rest of this informative article here —>